Immune checkpoint: The novel target for antitumor therapy

Immune checkpoint: The novel target for antitumor therapy

Inhibitory checkpoint molecules include programmed cell death-1 (PD-1), programmed cell death ligand-1 (PD-L1), cytotoxic T lymphocyte antigen-4 (CTLA-4), human endogenous retrovirus-H Long terminal repeat-associating 2 (HHLA2), B7 homolog 4 protein (B7-H4), T cell membrane protein-3 (TIM-3) and Lym...

Full description

Bibliographic Details
Main Authors: Xianghu Jiang, Guohong Liu, Yirong Li, Yunbao Pan
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Genes and Diseases
Subjects:
Circulating tumor DNA (ctDNA)
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)
Exosome
Immune checkpoint
Lymphocyte-activation gene 3 (LAG-3)
Programmed cell death protein ligand 1 (PD-L1)
Online Access:http://www.sciencedirect.com/science/article/pii/S2352304219301205

Internet

http://www.sciencedirect.com/science/article/pii/S2352304219301205

Similar Items